XII Medical

XII Medical, Inc. was founded in 2017 as a medical device development company. It is developing an implantable neurostimulation device aimed at alleviating sleep apnea. The company has developed a minimally invasive outpatient technology that prevents throat muscles from temporarily relaxing, avoiding airway obstruction during sleep and enabling patients to actively increase oropharyngeal airflow.